Tafenoquine succinate, >=95% (HPLC)

Code: sml0396-50mg D2-231

Biochem/physiol Actions

Tafenoquine is an antimalarial primaquine analog being investigated to treat and prevent Plasmodium vivax infections. It can eliminate both b...


read more

Your Price
£341.00 50MG
£409.20 inc. VAT

Biochem/physiol Actions

Tafenoquine is an antimalarial primaquine analog being investigated to treat and prevent Plasmodium vivax infections. It can eliminate both blood and liver stages of Plasmodium vivax. Tafenoquine has also been tested as a therapy for leishmaniasis.

Tafenoquine has been generally generated for oral administration and drug absorption increases when taken along with food. It is known to possess a longer half life.

Packaging

10, 50 mg in glass bottle

assay≥95% (HPLC)
colorwhite to beige
formpowder
InChI keyCQBKFGJRAOXYIP-UHFFFAOYSA-N
InChI1S/C24H28F3N3O3.C4H6O4/c1-14-11-20(32-4)30-22-18(29-15(2)7-6-10-28)13-19(31-3)23(21(14)22)33-17-9-5-8-16(12-17)24(25,26)27;5-3(6)1-2-4(7)8/h5,8-9,11-13,15,29H,6-7,10,28H2,1-4H3;1-2H2,(H,5,6)(H,7,8)
Quality Level100
SMILES stringOC(=O)CCC(O)=O.COc1cc(C)c2c(Oc3cccc(c3)C(F)(F)F)c(OC)cc(NC(C)CCCN)c2n1
solubilityDMSO: 5 mg/mL (clear solution)
storage conditiondesiccated
storage temp.2-8°C
Code
Description
Unit Size
List Price
Qty
SML0396-10MG
Unit:10MG
List Price: £94.50
Source:List Price
ADD
Cas Number106635-81-8
This product has met the following criteria: